{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T12:03:56Z","timestamp":1793189036712,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.bioorg.2025.108578","type":"journal-article","created":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T11:10:48Z","timestamp":1746875448000},"page":"108578","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Site-selective structural modification of toosendanin enables one-step synthesis of 12-hydroxyamoorastatin: A natural tautomeric antitumor lead with low toxicity"],"prefix":"10.1016","volume":"161","author":[{"given":"Qing-Yan","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ting","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Chao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing-Jie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dashan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dao-Feng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Dong","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2022","key":"10.1016\/j.bioorg.2025.108578_bb0005","first-page":"524","article-title":"CA Cancer","volume":"72","author":"Giaquinto","year":"2022","journal-title":"J. Clin."},{"key":"10.1016\/j.bioorg.2025.108578_bb0010","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12943-020-01283-6","article-title":"A novel HSP90 inhibitor targeting the C-terminal domain attenuates trastuzumab resistance in HER2-positive breast cancer","volume":"19","author":"Park","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bioorg.2025.108578_bb0015","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.canlet.2019.01.029","article-title":"C-terminal HSP90 inhibitor L80 elicits anti-metastatic effects in triple-negative breast cancer via STAT3 inhibition","volume":"447","author":"Cho","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bioorg.2025.108578_bb0020","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1021\/acsptsci.4c00234","article-title":"Promising G-Quadruplex-targeted Dibenzoquinoxaline Type-1 photosensitizer triggers DNA damage in triple-negative breast Cancer cells","volume":"7","author":"Zhang","year":"2024","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.bioorg.2025.108578_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116536","article-title":"Novel quinoxaline analogs as telomeric G-quadruplex ligands exert antitumor effects related to enhanced immunomodulation","volume":"274","author":"Wang","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108578_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.140556","article-title":"Diphenylaminothiophen-derived fluorescent ligands targeting mitochondrial DNA G-quadruplexes potentially for triple-negative breast cancer therapy","volume":"302","author":"Wang","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioorg.2025.108578_bb0035","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1039\/D3MD00431G","article-title":"A silicon-containing aryl\/penta-1,4-dien-3-one\/amine hybrid exhibits antiproliferative effects on breast cancer cells by targeting the HSP90 C-terminus without inducing heat-shock response","volume":"14","author":"Liao","year":"2023","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108578_bb0040","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202400870","article-title":"Synthesis of C3\u2032-Foused aryl\/Penta-1,4-Dien-3-one\/amine hybrids as HSP90C-terminal inhibitors","volume":"21","author":"Zheng","year":"2024","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.bioorg.2025.108578_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2024.129802","article-title":"Discovery of acetophenone\/piperazin-2-one hybrids as selective anti-TNBC cancer agents by causing DNA damage","volume":"108","author":"Zhang","year":"2024","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.108578_bb0050","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1021\/acs.orglett.4c00378","article-title":"Biomimetic Total synthesis of Bimagnolignan: a natural anti-breast Cancer agent","volume":"26","author":"Liu","year":"2024","journal-title":"Org. Lett."},{"key":"10.1016\/j.bioorg.2025.108578_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2023.129307","article-title":"Development of actein derivatives as potent anti-triple negative breast cancer agents","volume":"89","author":"Zhang","year":"2023","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.108578_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2023.129187","article-title":"Design, synthesis, and anti-triple negative breast cancer activity of novel Toosendanin derivatives","volume":"83","author":"Zhang","year":"2023","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.108578_bb0065","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1002\/ptr.4609","article-title":"Anticancer drugs from traditional toxic Chinese medicines","volume":"26","author":"Man","year":"2012","journal-title":"Phytother. Res."},{"key":"10.1016\/j.bioorg.2025.108578_bb0070","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1080\/10286020.2018.1451516","article-title":"Anti-cancer effect of toosendanin and its underlying mechanisms","volume":"21","author":"Zhang","year":"2019","journal-title":"J. Asian Nat. Prod. Res."},{"key":"10.1016\/j.bioorg.2025.108578_bb0075","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/CM9.0000000000003101","article-title":"Toosendanin: upgrade of an old agent in cancer treatment","volume":"22","author":"Li","year":"2024","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.bioorg.2025.108578_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115541","article-title":"Therapeutic potential of toosendanin: novel applications of an old ascaris repellent as a drug candidate","volume":"167","author":"Hu","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioorg.2025.108578_bb0085","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1055\/s-0029-1240902","article-title":"Toosendanin inhibits hepatocellular carcinoma cells by inducing mitochondria-dependent apoptosis","volume":"76","author":"He","year":"2010","journal-title":"Planta Med."},{"key":"10.1016\/j.bioorg.2025.108578_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2021.109739","article-title":"Toosendanin and isotoosendanin suppress triple-negative breast cancer growth via inducing necrosis, apoptosis and autophagy","volume":"351","author":"Zhang","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bioorg.2025.108578_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.118196","article-title":"Rosmarinic acid alleviates toosendanin-induced liver injury through restoration of autophagic flux and lysosomal function by activating JAK2\/STAT3\/CTSC pathway","volume":"330","author":"Luo","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bioorg.2025.108578_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2024.114631","article-title":"Toosendanin induces hepatotoxicity via disrupting LXR\u03b1\/Lipin1\/SREBP1 mediated lipid metabolism","volume":"187","author":"Chen","year":"2024","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.bioorg.2025.108578_bb0105","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.toxlet.2024.03.002","article-title":"Toosendanin induces hepatotoxicity by restraining autophagy and lysosomal function through inhibiting STAT3\/CTSC axis","volume":"394","author":"Luo","year":"2024","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.bioorg.2025.108578_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2022.104283","article-title":"Discovery of 29-O-acyl-toosendanin-based derivatives as potent anti-cancer agents","volume":"15","author":"Zou","year":"2022","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.bioorg.2025.108578_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.4837","article-title":"Determination of toosendanin and trans-anethole in Fructus Meliae Toosendan and Fructus Foeniculi by HPLC\u2013MS\/MS and GC\u2013MS\/MS in rat plasma and their potential herb\u2013herb interactions","volume":"34","author":"Yu","year":"2020","journal-title":"Biomed. Chromatogra."},{"key":"10.1016\/j.bioorg.2025.108578_bb0120","doi-asserted-by":"crossref","first-page":"6276","DOI":"10.1021\/acs.jmedchem.9b00917","article-title":"Designing around structural alerts in drug discovery","volume":"63","author":"Kalgutkar","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108578_bb0125","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1021\/ci300245q","article-title":"ToxAlerts: a web server of structural alerts for toxic chemicals and compounds with potential adverse reactions","volume":"52","author":"Sushko","year":"2012","journal-title":"J. Chem. Inf. Mod."},{"key":"10.1016\/j.bioorg.2025.108578_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106501","article-title":"Synthesis of structurally diverse derivatives of aconitine-type diterpenoid alkaloids and their anti-proliferative effects on canine breast cancer cells","volume":"135","author":"Zhang","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108578_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.118832","article-title":"An overview of the research progress on Aconitum carmichaelii Debx.:active compounds, pharmacology, toxicity, detoxification, and applications","volume":"337","author":"Liang","year":"2025","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bioorg.2025.108578_bb0140","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3390\/ijms19020376","article-title":"The effect of Triptolide in rheumatoid arthritis: from basic research towards clinical translation","volume":"19","author":"Fan","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.108578_bb0145","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/j.bmcl.2011.02.031","article-title":"Natural products-based insecticidal agents 9. Design, semisynthesis and insecticidal activity of 28-acyloxy derivatives of toosendanin against Mythimna separata Walker in vivo","volume":"21","author":"Xu","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.108578_bb0150","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1073\/pnas.0812839106","article-title":"Bimodal modulation of the botulinum neurotoxin protein-conducting channel","volume":"106","author":"Fischer","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bioorg.2025.108578_bb0155","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.160606","article-title":"Small-molecule PROTAC mediates targeted protein degradation to treat STAT3-dependent epithelial cancer","volume":"7","author":"Jin","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.bioorg.2025.108578_bb0160","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1016\/j.apsb.2023.05.006","article-title":"Isotoosendanin exerts inhibition on triple-negative breast cancer through abrogating TGF-\u03b2-induced epithelial\u2013mesenchymal transition via directly targeting TGF\u03b2R1","volume":"13","author":"Zhang","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bioorg.2025.108578_bb0165","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/BF01949897","article-title":"The structure of amoorastatone and the cytotoxic limonoid 12-hydroxyamoorastatin","volume":"35","author":"Polonsky","year":"1979","journal-title":"Experientia"},{"key":"10.1016\/j.bioorg.2025.108578_bb0170","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1248\/cpb.43.1171","article-title":"Cytotoxic Limonoids and Tetranortriterpenoids from Melia azedarach","volume":"43","author":"Itokawa","year":"1995","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.bioorg.2025.108578_bb0175","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1271\/bbb.66.1731","article-title":"Potent Limonoid insect Antifeedant from Melia azedarach","volume":"66","author":"Carpinella","year":"2002","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.bioorg.2025.108578_bb0180","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1021\/jf025811w","article-title":"Antifeedant and insecticide properties of a Limonoid from Melia azedarach (Meliaceae) with potential use for Pest management","volume":"51","author":"Carpinella","year":"2003","journal-title":"J. Agri. Food Chem."},{"key":"10.1016\/j.bioorg.2025.108578_bb0185","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/S0031-9422(00)89749-6","article-title":"Cytotoxic limonoids from Melia azedarach var. Japonica","volume":"36","author":"Ahn","year":"1994","journal-title":"Phytochemistry"},{"key":"10.1016\/j.bioorg.2025.108578_bb0190","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.fct.2017.04.039","article-title":"P53 tumor suppressor is required for efficient execution of the death program following treatment with a cytotoxic limonoid obtained from Melia azedarach","volume":"109","author":"Joray","year":"2017","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.bioorg.2025.108578_bb0195","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.steroids.2010.05.013","article-title":"New bufadienolides and C23 steroids from the venom of Bufo bufo gargarizans","volume":"75","author":"Tian","year":"2010","journal-title":"Steroids"},{"key":"10.1016\/j.bioorg.2025.108578_bb0200","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.tiv.2012.09.013","article-title":"Toosendanin induces apoptosis through suppression of JNK signaling pathway in HL-60 cells","volume":"27","author":"Ju","year":"2013","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.bioorg.2025.108578_bb0205","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.molcel.2007.11.015","article-title":"The DNA damage response: ten years after","volume":"28","author":"Harper","year":"2007","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bioorg.2025.108578_bb0210","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.gendis.2023.03.028","article-title":"DNA damage chemotherapeutic drugs suppress basal-like breast cancer growth by down-regulating the transcription of the FOXO1-KLF5 axis","volume":"11","author":"Cui","year":"2024","journal-title":"Genes Dis."},{"key":"10.1016\/j.bioorg.2025.108578_bb0215","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1038\/s12276-022-00863-4","article-title":"DNA damage response revisited: the p53 family and its regulators provide endless cancer therapy opportunities","volume":"54","author":"Abuetabh","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bioorg.2025.108578_bb0220","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41573-022-00571-8","article-title":"Drugging p53 in cancer: one protein, many targets","volume":"22","author":"Hassin","year":"2023","journal-title":"Nat. Rev. Drug Dis."},{"key":"10.1016\/j.bioorg.2025.108578_bb0225","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.tibs.2021.10.004","article-title":"Molecular mechanisms of heat shock factor 1 regulation","volume":"47","author":"Kmiecik","year":"2022","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bioorg.2025.108578_bb0230","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.7150\/thno.81847","article-title":"Role of p53 in breast cancer progression: an insight into p53 targeted therapy","volume":"13","author":"Marvalim","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.bioorg.2025.108578_bb0235","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/s41388-019-1016-y","article-title":"Heat-shock proteins: chaperoning DNA repair","volume":"39","author":"Dubrez","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.bioorg.2025.108578_bb0240","doi-asserted-by":"crossref","first-page":"14951","DOI":"10.1002\/jcp.28334","article-title":"RAS\/MAPK signaling functions in oxidative stress, DNA damage response and cancer progression","volume":"234","author":"Rezatabar","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bioorg.2025.108578_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111227","article-title":"Hydroxysafflor yellow a promotes apoptosis via blocking autophagic flux in liver cancer","volume":"136","author":"Wu","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioorg.2025.108578_bb0250","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910453","article-title":"Diosmin inhibits glioblastoma growth through inhibition of Autophagic flux","volume":"22","author":"Chang","year":"2021","journal-title":"Int. J. Mol. Sci."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825004584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825004584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T13:15:31Z","timestamp":1753449331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825004584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":50,"alternative-id":["S0045206825004584"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108578","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Site-selective structural modification of toosendanin enables one-step synthesis of 12-hydroxyamoorastatin: A natural tautomeric antitumor lead with low toxicity","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108578","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108578"}}